Income tax expense · 2018–2025
Legend Biotech income tax expense
$14.2M−24.9% · FY2025
Legend Biotech (LEGN) reported $14.2M in income tax expense for fiscal 2025, −24.9% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $14.2M | −24.9% | Open → |
| FY20242024-12-31 | $18.9M | +$20.8M | Open → |
| FY20232023-12-31 | −$1.9M | −$2.5M | Open → |
| FY20222022-12-31 | $625,000 | +$4.2M | Open → |
| FY20212021-12-31 | −$3.6M | +$38.3M | Open → |
| FY20202020-12-31 | −$41.9M | −$16.2M | Open → |
| FY20192019-12-31 | −$25.7M | −$26.9M | Open → |
| FY20182018-12-31 | $1.2M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2018–2025 compound annual growth +42.9%
Figures are reported under IFRS, in US dollars.
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Legend Biotech income tax expense |url=https://companiesranked.com/en/company/legend-biotech/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Legend Biotech income tax expense. CompaniesRanked. https://companiesranked.com/en/company/legend-biotech/income-tax-expenseBibTeX
@misc{companiesranked-en-company-legend-biotech-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Legend Biotech income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/legend-biotech/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001801198-26-000008 · March 10, 2026
{{cite web |title=Legend Biotech income tax expense — 20-F (0001801198-26-000008) |url=https://www.sec.gov/Archives/edgar/data/1801198/000180119826000008/legn-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-03-10}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.